# AAREYDRUGS — Aarey Drugs & Pharmaceuticals Limited

> Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS) on the NSE: 1,250 sessions of split-adjusted history from 2021.

Canonical: https://patternsradar.com/s/AAREYDRUGS

## Latest session

- Close: 81.2 INR (0.76% on the day), 2026-08-21
- Delivery: 20.66% of volume taken to demat (20-day average 88.94%)
- Volume: 6.99L shares, turnover ₹5.7Cr
- Relative volume: 5.55× of its own 20-day average

## Technicals

- RSI(14): 48.41
- ATR(14): 3.62
- SMA 50: 82.36, SMA 200: 77.55
- 52-week range: 50.31 – 100 (-18.8% from the high)

## Performance

- 1 week -3.18%, 1 month 5.18%, 3 months -3.03%
- 6 months 22.25%, 1 year 25.87%

## Fundamentals

- Market cap: 231 crore
- P/E (TTM): 47.32 — NULL when trailing earnings are negative or unfiled, never a misleading number
- EPS (TTM): 1.72 INR, split-adjusted to match the price series
- Revenue growth: -56.34% YoY, -76.45% QoQ
- Profit growth: -25.36% YoY, -34.27% QoQ

Compound annual growth, trailing-twelve-month against the same measure N years earlier:

| Window | Revenue | Profit |
| --- | --- | --- |
| 2y | -6.23% | -3.08% |
| 3y | 6.03% | -1.46% |
| 4y | -5.16% | -4.29% |

## Quarterly results

Last 8 filed quarters, standalone basis, in rupees crore as filed.

| Quarter | Revenue | Total expenses | Profit before tax | Net profit | EPS | Net margin |
| --- | --- | --- | --- | --- | --- | --- |
| 2024-09-30 | 105.1 | 103.4 | 1.7 | 1.6 | 1.14 | 1.52% |
| 2024-12-31 | 133.8 | 133.1 | 1.4 | 0.7 | 0.26 | 0.54% |
| 2025-03-31 | 108.1 | 114 | 1.6 | 0.5 | 0.04 | 0.43% |
| 2025-06-30 | 102.2 | 102 | 1.7 | 1.4 | 0.48 | 1.34% |
| 2025-09-30 | 84.2 | 83.5 | 1.5 | 1 | 0.72 | 1.22% |
| 2025-12-31 | 96.4 | 99.7 | 0.9 | 1.3 | 0.2 | 1.33% |
| 2026-03-31 | 189.5 | 187.8 | 1.3 | 1.6 | 0.55 | 0.82% |
| 2026-06-30 | 44.6 | 45.8 | 0.5 | 1 | 0.36 | 2.29% |

A quarterly filing with NSE carries a profit and loss only. There is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure in this dataset. EPS is restated onto the split-adjusted basis the price series uses; every rupee figure is exactly as filed.

## Shareholding

As filed for 2026-06-30:

- Promoter: 37.71%
- Public: 62.29%

Institutional and pledge percentages come from a filing stage whose backfill has reached about 1% of instruments, so they are absent here rather than zero.

## Recent filings

- 2026-08-14: results for 2026-06-30 standalone — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_187775_14082026204327_iXBRL_WEB.html
- 2026-07-21: shareholding for 2026-06-30 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1698826_21072026073942_WEB.xml
- 2026-05-30: results for 2026-03-31 standalone — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_165202_30052026224630_iXBRL_WEB.html
- 2026-04-20: shareholding for 2026-03-31 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1654655_20042026123653_WEB.xml
- 2026-02-11: results for 2025-12-31 standalone — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_142106_11022026191716_iXBRL_WEB.html
- 2026-01-20: shareholding for 2025-12-31 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1606020_20012026060557_WEB.xml
- 2025-11-14: results for 2025-09-30 standalone — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_127776_14112025113151_iXBRL_WEB.html
- 2025-10-20: shareholding for 2025-09-30 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1554302_20102025011725_WEB.xml

Dated by the day the company broadcast the filing. 47 events are indexed for this instrument.

## About the instrument

- Listed: 2021-08-06 — latest session 2026-08-21 (1,250 sessions)
- ISIN: INE198H01019
- Series: EQ
- Liquidity rank: #1618 by 20-day average turnover — not index membership

Delivery figures come from NSE's daily reports and are unavailable for older sessions. Prices are end-of-day, split- and bonus-adjusted, from the eod2 dataset.

Charts and the full bar history are on the rendered page: https://patternsradar.com/s/AAREYDRUGS.